Next Article in Journal / Special Issue
A Multi-Camera System for Bioluminescence Tomography in Preclinical Oncology Research
Previous Article in Journal
Non-Invasive Screening Tools for Down’s Syndrome: A Review
Previous Article in Special Issue
Quantification of Right and Left Ventricular Function in Cardiac MR Imaging: Comparison of Semiautomatic and Manual Segmentation Algorithms
Review

Current Staging Procedures in Urinary Bladder Cancer

1
Department of Urology, Klinikum rechts der Isar, Technical University Munich, Ismaniger Str. 22, 81675 Munich, Germany
2
Department of Radiology, Klinikum rechts der Isar, Technical University Munich, Ismaniger Str. 22, 81675 Munich, Germany
3
Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Ismaniger Str. 22, 81675 Munich, Germany
*
Author to whom correspondence should be addressed.
Diagnostics 2013, 3(3), 315-324; https://doi.org/10.3390/diagnostics3030315
Received: 17 May 2013 / Revised: 13 June 2013 / Accepted: 18 June 2013 / Published: 25 June 2013
(This article belongs to the Special Issue Advance in Molecular Diagnostics and Imaging)
Currently computed tomography (CT) represents the most widely used standard imaging modality in muscle-invasive urinary bladder cancer. Visualization of local tumor or depth of invasion as well as lymph node staging, however, is often impaired. Magnetic resonance imaging (MRI) with diffusion-weighted sequences, determination of apparent diffusion coefficient (ADC) values or utilization of superparamagnetic iron nanoparticles potentially exhibits advantages in the assessment of local tumor or lymph node involvement and therefore might play a role in routine staging of urinary bladder cancer in the future. Likewise, positron emission tomography (PET) with the currently utilized tracers 18F-FDG, 11C-choline and 11C-acetate is investigated in bladder cancer patients—mostly in combination with diagnostic CT. Although promising results could be obtained for these PET/CT examinations in smaller series, their true value cannot be determined at present. View Full-Text
Keywords: urinary bladder cancer; MRI; PET/CT; FDG; choline; actetate urinary bladder cancer; MRI; PET/CT; FDG; choline; actetate
Show Figures

Graphical abstract

MDPI and ACS Style

Maurer, T.; Horn, T.; Heck, M.; Gschwend, J.E.; Eiber, M.; Beer, A.J. Current Staging Procedures in Urinary Bladder Cancer. Diagnostics 2013, 3, 315-324. https://doi.org/10.3390/diagnostics3030315

AMA Style

Maurer T, Horn T, Heck M, Gschwend JE, Eiber M, Beer AJ. Current Staging Procedures in Urinary Bladder Cancer. Diagnostics. 2013; 3(3):315-324. https://doi.org/10.3390/diagnostics3030315

Chicago/Turabian Style

Maurer, Tobias, Thomas Horn, Matthias Heck, Jürgen E. Gschwend, Matthias Eiber, and Ambros J. Beer 2013. "Current Staging Procedures in Urinary Bladder Cancer" Diagnostics 3, no. 3: 315-324. https://doi.org/10.3390/diagnostics3030315

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop